Revisit current Covid-19 vaccine policy, it may create disparity: Supreme Court to Centre
NEW DELHI: The Supreme Court has directed the Centre to revisit its COVID-19 vaccine pricing policy, saying it would prima...
NEW DELHI: The Supreme Court has directed the Centre to revisit its COVID-19 vaccine pricing policy, saying it would prima...
NEW DELHI: Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine...
NEW DELHI: A total of 86,023 beneficiaries in the age group of 18-44 years received their first dose of COVID...
NEW DELHI: More than 78 lakh COVID-19 vaccine doses are still available with the states and Union Territories (UTs) which...
NEW DELHI: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday spoke out about the pressures he was under...
NEW DELHI: Ministry of Civil Aviation (MoCA) and Directorate General of Civil Aviation (DGCA) have granted a conditional exemption for...
NEW DELHI: Serum Institute of India (SII) -- the maker of the most used COVID-19 vaccine in the country --...
NEW DELHI: India, despite severe constraints and within its own limited resources, has tried to "walk the talk" on vaccine...
NEW DELHI: The government of India has leading the fight against the COVID19 pandemic. Vaccination is a crucial pillar of...
US pharmaceuticals giant Pfizer is planning a new version of its coronavirus vaccine that can be stored in a standard...